Dr. Madhu Gargesha of BioInVision presented a paper titled “MSC pre-treatments lead to better cell survival in mouse models of liver disease: A CryoViz Study” at the American Association of Immunologists (AAI) 2016 Conference in Seattle, Washington, USA, May 13-16 2016. The presentation was very well received and generated a lot of interest in the MERLIN project. You can find more details about the Conference here.
- CIRM invests $1.3 million to study stem cells in metabolic #liver disease t.co/30ltYi5Vsr via @CIRMnews Time ago 5 Days via Twitter Web Client
- @fp7Merlin #publication Immunomodulation by Therapeutic Mesenchymal Stromal Cells #MSC) Is Triggered Through Phago… t.co/IfgWoWMdkl Time ago 6 Days via Twitter Web Client
- @LiverTrust welcomes the announcement that the National Institute for Health and Care Excellence has approved the… t.co/M9RQB6jEeP Time ago 10 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.